Results 681-700 of 2,022 for speaker:John Brassil
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: I welcome the witnesses and thank them for attending the meeting. I have some general questions. We have heard that approximately 14% of the health budget is spent on drugs. Could we get a breakdown of how much of that 14% is spent on high-tech or orphan drugs in order that we can make comparisons? Could Professor Barry tell us where we lie in comparison with other EU countries on drug...
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: Outside, did Professor Barry say that his team had four people?
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: Sorry.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: Have the nine extra members been approved?
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: The NCPE is working at 50% of capacity.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: Actually, I will rephrase that. The NCPE needs 100% more staff to do the job required of it.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: What of a review of a drug that does not pass assessment?
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: Mr. Hennessy or Mr. Flanagan might say when there will be a further decision on Respreeza. A number of patients have been operating on a month-to-month basis, which is unsatisfactory, as the witnesses can imagine.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: My question is along the same lines. In any walk of life, organisation or process review a decision is reached based on best knowledge and information, which is very much respected. Is there a review mechanism with regard to the final decision of the witnesses, whereby somebody else can take a clean look at it? Two outcomes can differ. I am not saying the witnesses' analysis would be...
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: Another meeting is probably necessary at this stage.
- Joint Oireachtas Committee on Health: Funding of Orphan Drugs: Discussion (12 Jul 2017)
John Brassil: I welcome the witnesses and apologise to Mr. Lodge and Ms Clair Kelly. Had I known that people with Duchenne muscular dystrophy were being represented here this morning, I would have pursued the same line of questioning as I had done with Respreeza for alpha-1. I am a substitute on this committee for Deputy Kelleher and I had not seen that but I will try to follow up by email on the...
- Questions on Promised Legislation (13 Jul 2017)
John Brassil: The same applies to everyone.
- Written Answers — Department of Housing, Planning, Community and Local Government: Tenant Purchase Scheme (13 Jul 2017)
John Brassil: 48. To ask the Minister for Housing, Planning, Community and Local Government the status of the tenant purchase scheme (details supplied); and if he will make a statement on the matter. [33105/17]
- Written Answers — Department of Arts, Heritage and the Gaeltacht: National Parks Projects (13 Jul 2017)
John Brassil: 457. To ask the Minister for Arts, Heritage and the Gaeltacht further to Parliamentary Question No. 776 of 17 January 2017, if the updated strategic rhododendron management plan has been finalised; her views on the fact that the spread of rhododendron is accelerating faster than current resources can combat and is seriously threatening the indigenous natural flora and fauna of Killarney...
- Written Answers — Department of Health: Home Care Packages Provision (13 Jul 2017)
John Brassil: 510. To ask the Minister for Health the status of the home care package application for a person (details supplied); and if he will make a statement on the matter. [33648/17]
- Written Answers — Department of Health: Drugs Payment Scheme (13 Jul 2017)
John Brassil: 511. To ask the Minister for Health the status of an application for a drugs payment scheme card for a person (details supplied); and if he will make a statement on the matter. [33649/17]
- Written Answers — Department of Health: Hospitals Capital Programme (13 Jul 2017)
John Brassil: 512. To ask the Minister for Health if the capital submission that has been finalised by University Hospital Kerry in respect of a dedicated obstetric theatre is sanctioned for approval and escalation to the acute hospitals division as a matter of urgency in order for consideration of funding by the national estates; and if he will make a statement on the matter. [33653/17]
- Written Answers — Department of Health: Medicinal Products Prices (13 Jul 2017)
John Brassil: 616. To ask the Minister for Health the number of medicines that have had their price reduced as of 1 July 2017 with reference to the framework agreement on the supply and pricing of medicines; the details of each medicine; and the extent of the price cut. [33879/17]
- Written Answers — Department of Health: Primary Care Reimbursement Service Payments (13 Jul 2017)
John Brassil: 617. To ask the Minister for Health if online PCRS processing has now been extended to dentists and clinical dental technicians. [33880/17]
- Written Answers — Department of Health: Medical Card Administration (13 Jul 2017)
John Brassil: 618. To ask the Minister for Health when the web based paperless medical card application process to reduce the number of paper based applications will be implemented. [33881/17]